64 related articles for article (PubMed ID: 9854483)
21. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
22. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D
Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
[TBL] [Abstract][Full Text] [Related]
24. Pathologic models to predict outcome for women with endometrial adenocarcinoma: the importance of the distinction between surgical stage and clinical stage--a Gynecologic Oncology Group study.
Zaino RJ; Kurman RJ; Diana KL; Morrow CP
Cancer; 1996 Mar; 77(6):1115-21. PubMed ID: 8635132
[TBL] [Abstract][Full Text] [Related]
25. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas.
Nguyen TV; Yueh B
Cancer; 2002 Aug; 95(3):553-62. PubMed ID: 12209747
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
27. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of cell kinetics in endometrial adenocarcinoma.
Mariani L; Conti L; Antenucci A; Vercillo M; Atlante M; Gandolfo GM
Anticancer Res; 2000; 20(5B):3569-74. PubMed ID: 11131664
[TBL] [Abstract][Full Text] [Related]
29. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer.
Zusterzeel PL; Bekkers RL; Hendriks JC; Neesham DN; Rome RM; Quinn MA
Acta Obstet Gynecol Scand; 2008; 87(2):240-6. PubMed ID: 18231895
[TBL] [Abstract][Full Text] [Related]
31. DNA ploidy is an independent prognostic indicator of overall survival in stage I endometrial endometrioid carcinoma.
Santala M; Talvensaari-Mattila A
Anticancer Res; 2003; 23(6D):5191-6. PubMed ID: 14981988
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for postoperative complications in oral cancer and their prognostic implications.
de Melo GM; Ribeiro KC; Kowalski LP; Deheinzelin D
Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):828-33. PubMed ID: 11448358
[TBL] [Abstract][Full Text] [Related]
33. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K
Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
[TBL] [Abstract][Full Text] [Related]
34. Prognostic model of event-free survival for patients with androgen-independent prostate carcinoma.
Shulman MJ; Benaim EA
Cancer; 2005 Jun; 103(11):2280-6. PubMed ID: 15844202
[TBL] [Abstract][Full Text] [Related]
35. A prognostic index (bladder prognostic index) for bilharzial-related invasive bladder cancer.
Khaled H; El Hattab O; Moneim DA; Kassem HA; Morsi A; Sherif G; Darwish T; Gaafar R
Urol Oncol; 2005; 23(4):254-60. PubMed ID: 16018940
[TBL] [Abstract][Full Text] [Related]
36. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
37. Low-risk endometrial carcinoma: assessment of a treatment policy based on tumor ploidy and identification of additional prognostic indicators.
Lim P; Aquino-Parsons CF; Wong F; Dupuis B; Phillips D; Zhou C; Gilks CB
Gynecol Oncol; 1999 May; 73(2):191-5. PubMed ID: 10329033
[TBL] [Abstract][Full Text] [Related]
38. Ribosomal DNA methylation in patients with endometrial carcinoma: an independent prognostic marker.
Powell MA; Mutch DG; Rader JS; Herzog TJ; Huang TH; Goodfellow PJ
Cancer; 2002 Jun; 94(11):2941-52. PubMed ID: 12115383
[TBL] [Abstract][Full Text] [Related]
39. A strong prognostic variable in endometrial carcinoma: flow cytometric S-phase fraction.
Kaleli S; Kösebay D; Beşe T; Demirkiran F; Oz UA; Arvas M; Aydinli K; Erkün E
Cancer; 1997 Mar; 79(5):944-51. PubMed ID: 9041157
[TBL] [Abstract][Full Text] [Related]
40. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial.
Creutzberg CL; van Putten WL; Wárlám-Rodenhuis CC; van den Bergh AC; de Winter KA; Koper PC; Lybeert ML; Slot A; Lutgens LC; Stenfert Kroese MC; Beerman H; van Lent M;
J Clin Oncol; 2004 Apr; 22(7):1234-41. PubMed ID: 15051771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]